(Q39153109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Curcumin targets the AKT-mTOR pathway for uterine leiomyosarcoma tumor growth suppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

8

Nobuo Yaegashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

Mari Tadakawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

Tze Fang Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

Kenji Tsuiji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

5

Akiko Kondo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Takashi Takeda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Bin Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

11 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

354-363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23666561%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-013-0563-4

1 March 2020

exact match

0 references

cites work

Clinical management of uterine sarcomas

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Antiangiogenesis agents in the treatment of soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin disrupts the Mammalian target of rapamycin-raptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Induction of apoptosis in human lung cancer cells by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0563-4

Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase

21 January 2018

1 reference

12 December 2020

Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway

1 reference

12 December 2020

Biotransformation of curcumin through reduction and glucuronidation in mice.

1 reference

12 December 2020

Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma

1 reference

12 December 2020

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

1 reference

12 December 2020

Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway

1 reference

12 December 2020

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

1 reference

12 December 2020

Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study

1 reference

12 December 2020